Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-19-005447
Filing Date
2019-09-25
Accepted
2019-09-25 16:58:08
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 a2239748z424b5.htm 424B5 423863
2 G131163.JPG g131163.jpg GRAPHIC 20669
3 G350387.JPG g350387.jpg GRAPHIC 25351
4 G776483.JPG g776483.jpg GRAPHIC 93514
5 G551433.JPG g551433.jpg GRAPHIC 102474
  Complete submission text file 0001047469-19-005447.txt   758659
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-230674 | Film No.: 191114709
SIC: 2834 Pharmaceutical Preparations